Publications by authors named "N Minshall"

Trypanosoma brucei is the causal agent of African Trypanosomiasis in humans and other animals. It maintains a long-term infection through an antigenic variation based population survival strategy. To proliferate in a mammal, T.

View Article and Find Full Text PDF

Despite their abundance, mid-sized RNAs (30-300 nt) have not been extensively studied by high-throughput sequencing, mostly due to selective loss in library preparation. The authors propose simple and inexpensive modifications to the Illumina TruSeq protocol (ncRNAseq), allowing the capture and sequencing of mid-sized non-coding RNAs without detriment to the coverage of coding mRNAs. This protocol is coupled with a two-step alignment: a pre-alignment to a curated non-coding genome, passing only the non-mapping reads to a standard genomic alignment.

View Article and Find Full Text PDF

Reverse transcription is the first step of most analyses of gene expression, yet the quantitative biases it introduces are largely overlooked. Following a series of purpose-designed systematic experiments we cherry-pick examples of various biases introduced by reverse transcription, and alert the "gene expression community" to the pitfalls and improved practice of this fundamental technique.

View Article and Find Full Text PDF

P-bodies are cytoplasmic ribonucleoprotein granules involved in posttranscriptional regulation. DDX6 is a key component of their assembly in human cells. This DEAD-box RNA helicase is known to be associated with various complexes, including the decapping complex, the CPEB repression complex, RISC, and the CCR4/NOT complex.

View Article and Find Full Text PDF
Article Synopsis
  • eIF4E1b is a cap-binding protein similar to eIF4E1a, and is primarily found in oocytes of mouse, Xenopus, and zebrafish, functioning as part of a translation repressor complex.
  • Researchers examined the interactions of eIF4E1b with cap analogues using fluorescence techniques and structural modeling, revealing that it binds to caps less effectively than eIF4E1a due to specific amino acid differences.
  • Key findings indicate that eIF4E1b's cap-binding ability is enhanced by certain chemical modifications and that mutations in its distinguishing amino acids can significantly affect its cap-binding strength compared to eIF4E1a.
View Article and Find Full Text PDF